Pfizer's best-seller Lipitor, which ranked number 6 last year, fell six places in the ranking to number 12, according to the listing compiled by data provider IMS Health Next year, it will be a cheap generic, too. The first copycat versions, made by companies other than Pfizer, will be launched in November.
Until then, Lipitor will remain the best-selling drug in the country. The number of prescriptions for the drug, used to lower cholesterol, have fallen 38% since 2006. IMS says that sales have fallen 16% in that time, buoyed by increases in the price of the pill.
In the entire listing of the 25 most popular drugs, which I've included below, there are only three branded medicines: Lipitor, Plavix, the blood-thinner made by Sanofi-Aventis and Bristol-Myers Squibb that clocks in at number 23 and Singulair, the asthma and allergy pill from Merck, which ranks number 25. (Click here for The Best-Selling Drugs In America.)
This is a snapshot of the decreasing footprint of the world's largest drug companies. Where once they sold pills to everyone (the list is full of drugs that used to be big moneymakers for Merck and Pfizer and Novartis and Bristol that are now commodities) now they make niche medicines for narrowly defined populations of people. Plavix and Singulair both go off patent over the next couple years, ending the age of mass-market medicines completely.
The most popular drug, as in previous years, is the combination of hydrocodone and acetaminophen -- better known by its old brand name, Vicodin. As I wrote last year, Vicodin's popularity has been constant, even when a panel of advisors to the Food and Drug Administration recommended it should be pulled from the market because of the danger acetaminophen overdose poses to the liver. The FDA has responded to the concerns by asking manufacturers to limit the amount of acetaminophen in these products.
IMS, which tracks data at the pharmacy data for drug companies, also saw other signs that things are getting tougher for drug companies. The overall volume of prescriptions increased at barely more than 1% last year, and the number of visits to health care providers by patients decreased 4%. Spending on medicines increased 2.3%. In another sign of the times, antipsychotics, which had been the most lucrative medicines in the U.S., lost that title because of the patent expiration of Johnson & Johnson's Risperdal. The new top category? Cancer drugs, which seem to get more expensive every time a new one is approved. (The most recent, Yervoy from Bristol-Myers, costs $120,000 per patient.)
The full list is below. I've bolded the drugs that are currently protected by patents -- that is, not generics. In cases where it looks as if there was absolutely crazy 5-year growth in use, what you're actually seeing is the change from the first year when generics are available. This is an artifact of the IMS data. More data and analysis can be found on the IMS web site.
The Most Popular Drugs | ||||
The most prescribed drugs according to IMS Health. Prescriptions in millions. Branded drugs are in bold. |
||||
2010 | 1-year growth (%) | 5-year growth (%) | ||
Drug (brand name) use | 3995.2 | 1.16% | 7.79% | |
1 | hydrocodone/acetaminophen (Vicodin) pain | 131.2 | 2.34% | 16.73% |
2 | simvastatin (Zocor) high cholesterol | 94.1 | 12.29% | 553.47% |
3 | lisinopril high blood pressure | 87.4 | 5.56% | 34.05% |
4 | levothyroxine sodium (Synthroid) hypothyroid | 70.5 | 6.82% | 41.57% |
5 | amlodipine besylate (Norvasc) high blood pressure. | 57.2 | 11.50% | NA |
6 | omeprazole (Prilosec) acid reflux | 53.4 | 17.62% | 196.67% |
7 | azithromycin (Zithromax) antibiotic | 52.6 | -2.23% | 44.11% |
8 | amoxicillin antibiotic | 52.3 | -0.19% | -4.39% |
9 | metformin HCL (Glucophage) diabetes | 48.3 | 9.03% | 25.78% |
10 | hydrochlorothiazide high blood pressure | 47.8 | -0.21% | -0.42% |
11 | alprazolam (Xanax) anxiety | 46.3 | 5.47% | 23.14% |
12 | Lipitor (atorvastatin) high cholesterol | 45.3 | -12.38% | -38.78% |
13 | furosemide high blood pressure | 43.4 | -0.23% | -2.03% |
14 | metoprolol tartrate (Lopressor) high blood pressure |
38.9 | -5.35% | 33.22% |
15 | zolpidem tartrate (Ambien) insomnia | 38 | 8.26% | NA |
16 | atenolol high blood pressure | 36.3 | -7.63% | -21.26% |
17 | sertraline HCL (Zoloft) depression | 35.7 | 4.39% | 230.56% |
18 | metoprolol succinate (Toprol) blood pressure | 33 | 22.68% | 5400.00% |
19 | citalopram (Celexa) depression | 32.1 | 18.45% | 129.29% |
20 | warfarin sodium (Coumadin) blood thinner | 32 | 1.27% | 19.85% |
21 | oxycodone/acetaminophen pain | 31.9 | 5.63% | 39.91% |
22 | ibuprofen pain | 31.1 | 2.64% | 16.04% |
23 | Plavix (clopidogrel) heart disease | 29.5 | -1.34% | 60.33% |
24 | gabapentin (Neurontin) | 29.3 | 15.35% | 58.38% |
25 | Singulair (montelukast) allergies |
28.7 | 0.35% | 2.14% |
The Most Popular Drugs. | ||||
The most prnescribed drugs according to IMS Health. Prescriptions in millions. | ||||
2010 | 1-year growth (%) | 5-year growth (%) | ||
Drug (brand name) use | 3995.2 | 1.16% | 7.79% | |
1 | hydrocodone/acetaminophen (Vicodin) pain | 131.2 | 2.34% | 16.73% |
2 | simvastatin (Zocor) high cholesterol | 94.1 | 12.29% | 553.47% |
3 | lisinopril high blood pressure | 87.4 | 5.56% | 34.05% |
4 | levothyroxine sodium (Synthroid) hypothyroid | 70.5 | 6.82% | 41.57% |
5 | amlodipine besylate (Norvasc) high blood pressure. | 57.2 | 11.50% | NA |
6 | omeprazole (Prilosec) acid reflux | 53.4 | 17.62% | 196.67% |
7 | azithromycin (Zithromax) antibiotic | 52.6 | -2.23% | 44.11% |
8 | amoxicillin antibiotic | 52.3 | -0.19% | -4.39% |
9 | metformin HCL (Glucophage) diabetes | 48.3 | 9.03% | 25.78% |
10 | hydrochlorothiazide high blood pressure | 47.8 | -0.21% | -0.42% |
11 | alprazolam (Xanax) anxiety | 46.3 | 5.47% | 23.14% |
12 | Lipitor (atorvastatin) high cholesterol | 45.3 | -12.38% | -38.78% |
13 | furosemide high blood pressure | 43.4 | -0.23% | -2.03% |
14 | metoprolol tartrate | 38.9 | -5.35% | 33.22% |
15 | zolpidem tartrate (Ambien) insomnia | 38 | 8.26% | NA |
16 | atenolol high blood pressure | 36.3 | -7.63% | -21.26% |
17 | sertraline HCL (Paxil) depression | 35.7 | 4.39% | 230.56% |
18 | metoprolol succinate (Toprol) blood pressure | 33 | 22.68% | 5400.00% |
19 | citalopram (Celexa) depression | 32.1 | 18.45% | 129.29% |
20 | warfarin sodium (Coumadin) blood thinner | 32 | 1.27% | 19.85% |
21 | oxycodone/acetaminophen (Oxycontin) pain | 31.9 | 5.63% | 39.91% |
22 | ibuprofen pain | 31.1 | 2.64% | 16.04% |
23 | Plavix (clopidogrel) heart disease | 29.5 | -1.34% | 60.33% |
24 | gabapentin (Neurontin) | 29.3 | 15.35% | 58.38% |
25 | Singulair ( | 28.7 | 0.35% | 2.14% |